United States Digital Diabetes Management Market

United States Digital Diabetes Management Market Size and Share:

The United States digital diabetes management market size was valued at USD 3.92 Billion in 2024. Looking forward, the market is expected to reach USD 17.23 Billion by 2033, exhibiting a CAGR of 17.89% during 2025-2033. The market is fueled by the rising incidence of diabetes, heightened awareness about self-management devices, and increased uptake of digital healthcare technologies. Favorable government policies, increasing healthcare expenditure, and movement toward value-based care also push the adoption of digital solutions. Collaborations between tech firms and healthcare providers are further influencing the United States digital diabetes management market share.

One of the most significant drivers of the United States digital diabetes management market is the high and continually rising prevalence of diabetes across the country. The US has a high prevalence of both Type 1 and Type 2 diabetes, and lifestyle factors like diet, obesity, and physical inactivity have all been implicated in increasing the disease burden. This put a significant burden on the healthcare system and prompted action toward adopting preventive and self-management measures. Digital technologies, including continuous glucose monitors (CGMs), mobile apps, and intelligent insulin pens, are being used more frequently to enable patients to manage their condition at home more effectively. They enable users to track their glucose levels, receive reminders about medications, and gain access to personalized advice, diminishing the need for repeated in-office visits. The prevalence of smartphone and wearable device use across the region further fuels the growth of United States digital diabetes management market outlook and becomes a critical element in chronic disease treatment plans across the country.

To get more information on this market, Request Sample

The second leading factor is the pro-innovation ecosystem of health technology, insurance support, and public policy that exists in the United States alone. The US boasts a well-established digital health market, with several startups and incumbents investing in newer diabetes management platforms. These encompass AI-driven analytics, cloud-based monitoring platforms, and telemedicine platforms that enable remote connectivity of patients with healthcare professionals. US health insurers are rapidly covering digital diabetes tools as part of chronic disease management programs, promoting their utilization through reimbursement methodologies and value-based care strategies. In addition, federal programs such as Medicare and Medicaid have extended coverage for products like CGMs, making them more accessible to elderly and low-income citizens. The movement toward interoperability and data fusion among electronic health records (EHRs) also facilitates seamless care coordination. These synergistic influences like technological advances, encouraging reimbursement policy, and an emphasis on coordinated care, are driving digital diabetes solution adoption and redefining chronic disease management nationwide.

United States Digital Diabetes Management Market Trends:

Digital Integration and Technological Advancements

Technological advancements are at the forefront of developing the United States digital diabetes management market. The convergence of smartphones, wearable technology, and cloud-based platforms has transformed the monitoring and control of diabetes. Patients can now access real-time information through continuous glucose monitors (CGMs), insulin pumps, and mobile apps that offer real-time feedback on glucose levels, eating habits, exercise routines, and medication timing. For example, LillyDirect, a new digital healthcare platform for Americans with diabetes, obesity, and migraines, was introduced by Eli Lilly and Company in January 2024. Personalized support, direct home delivery of some Lilly drugs, and access to independent healthcare providers are just a few of the illness management resources that LillyDirect offers. In the United States, with high smartphone penetration and high consumer adoption of health technologies, these devices are quickly going mainstream. Cloud-based solutions also enable easy sharing of data between patients and healthcare providers, promoting greater collaboration and more effective treatment plans. Large technology companies are moving into the market, working with healthcare providers to create easy-to-use platforms that are integrated with other monitoring health tools. This expanding universe of networked devices and applications is turning diabetes care into a more accessible, effective, and technology-enabled experience, which also supports the United States digital diabetes management market demand.

Increased Need for Personalized and Self-Care

With the number of diabetes sufferers rising in the United States, so does the need for digital tools for supporting personalized and effective self-care. In 2024, 38.5 million adults in the United States between the ages of 20 and 79 were diagnosed with diabetes, according to the International Diabetes Federation (IDF). By 2050, this figure is expected to rise to 43.0 million. Patients are looking for solutions that extend beyond simple tracking and provide insights specific to their individual health conditions and lifestyles. Most Americans expect health technologies today to be personalized, easy to use, and supportive of their objectives, whether weight management, blood glucose control, or medication compliance. Healthcare digital platforms are adapting to address this by adding artificial intelligence and machine learning to examine patterns and provide guidance on what to do. This customization empowers users to manage their health more effectively and with greater confidence. Educational materials and virtual coaching functionality are also being integrated into applications to educate users about their condition and motivate them. The US market is best poised for these United States digital diabetes management market trends, given its high consumer health orientation and prevalence of digital health application use.

Remote Monitoring and Proactive Healthcare Models

Remote tracking and early intervention are increasingly becoming part of diabetes care in the United States, prompted by the move toward value-based healthcare and minimizing long-term healthcare expenses. For instance, in June 2024, Indianapolis-based Prevounce Health introduced the Pylo GL1-LTE, the company’s very first remote blood glucose monitoring system. The novel device has been clinically verified and integrates with several cellular networks in order to provide dependable data transfer across the US. Diabetes management platforms increasingly feature remote patient tracking by healthcare professionals, monitoring of changes in health indicators, and fast reaction to possible complications. This live connectivity is particularly valuable in rural and disadvantaged communities where specialist access could be limited. With reimbursement policies and regulatory support increasingly covering remote patient monitoring (RPM), both providers and patients are embracing these models as business as usual. Telehealth service integration also promotes patient engagement by offering more regular check-ins and medication adjustments. Hospitals and clinics throughout the US are building digital infrastructures that enable such proactive models of care with the goal of early identification of issues, better outcomes, and fewer hospital admissions. This trend is shifting diabetes care to a more responsive and patient-focused system, which further contributes to the United States digital diabetes management market growth.

United States Digital Diabetes Management Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the United States digital diabetes management market, along with forecasts at the country and regional levels from 2025-2033. The market has been categorized based on product type and device type.

Analysis by Product Type:

• Smart Glucose Meter
• Smart Insulin Pumps
• Smart Insulin Pens
• Apps

Smart glucose meters are crucial devices for the United States digital diabetes management market. They connect to smartphones and apps to display real-time blood glucose levels, trend lines, and alert features. Their convenience, user-friendliness, and compatibility with cloud platforms make them favorite choices for continuous, convenient self-monitoring and data transmission to healthcare professionals.

Smart insulin pumps dispense accurate insulin doses according to continuous glucose monitoring and personalized user settings. In the United States, they are becoming more popular for complex diabetes treatment because they can automate insulin delivery, minimize human error, and integrate with digital ecosystems. Their closed-loop system improves patient safety, control, and long-term blood glucose management.

Smart insulin pens are a digital upgrade to the old-school pen, recording dosage, timing, and history of injections. They are popular in the United States due to their affordability and integration with health applications. The pens assist patients in sticking to prescription schedules while facilitating physicians to view injection history, enhancing overall diabetes treatment compliance and personalization.

Mobile apps play a central role in the US digital diabetes management market, offering features like blood sugar tracking, diet logs, reminders, and integration with other devices. They empower users with personalized insights, real-time feedback, and remote support from care teams. Their convenience and functionality enhance engagement, self-care, and long-term diabetes control.

Analysis by Device Type:

• Handheld Devices
• Wearable Devices

Handheld devices in the United States digital diabetes management market are smart glucose meters, insulin pens, and data reader portable readers. They provide on-the-go monitoring and regulation, making them suitable for users with active lifestyles. Portability, simplicity, and connection to mobile apps enable real-time monitoring, customized alerts, and improved diabetes self-management and communication between healthcare providers and patients.

Wearable devices, such as continuous glucose monitors (CGMs) and insulin patches, are transforming diabetes care in the US by offering round-the-clock monitoring without the need for frequent finger pricks. These devices continuously collect glucose data and sync with smartphones or cloud platforms, enabling proactive management, timely interventions, and improved health outcomes through real-time insights and automated alerts.

Regional Analysis:

• Northeast 
• Midwest
• South
• West

As per the United States digital diabetes management market analysis, Northeast has high adoption of digital diabetes management solutions owing to developed healthcare infrastructure and high levels of awareness. Smart devices and remote monitoring solutions have demand propelled by urban hubs such as New York and Boston. The area has access to concentrated healthcare networks and advanced insurance schemes facilitating digital integration and chronic disease management.

The Midwest sees increasing diabetes incidence and the growth of telehealth services driving demand for digital diabetes management solutions. The urban-rural blend of the region maximizes its benefits from remote monitoring technologies and app-based solutions addressing access disparities. Public health programs and rising healthcare digitization also drive adoption across varied population groups.

The South has the US's second-highest diabetes burden, and so it's an important region for digital diabetes management expansion. More awareness campaigns, expansion of telemedicine, and government health initiatives are fueling adoption of mobile apps and smart devices. Wearable technologies are particularly useful in rural areas, where they offer constant monitoring and minimize reliance on on-site care.

The West region, dominated by states such as California and Washington, is the epicenter of innovation in digital health. Adoption of high tech, robust startup ecosystems, and pro-policy have led to accelerated adoption of intelligent diabetes management solutions. Consumers in this region prefer integrated digital platforms, wearable devices, and individualized care models that conform to tech-savvy lifestyles.

Competitive Landscape:

As observed through the United States digital diabetes management market forecast, several major companies are taking significant steps to innovate, expand access, and enhance patient outcomes. Companies like Dexcom, Abbott, Medtronic, and Insulet are leading advancements in continuous glucose monitoring (CGM) and insulin delivery systems, introducing devices with greater accuracy, longer wear times, and smartphone integration. These firms are also focusing on interoperability, allowing their devices to sync with popular mobile apps and electronic health records, enabling seamless data sharing between patients and healthcare providers. Tech giants such as Apple and Google are entering the space, leveraging their platforms to offer diabetes-focused health tracking and AI-powered insights. Additionally, partnerships between MedTech firms and health insurers are expanding reimbursement for digital tools, increasing affordability and access. Startups are contributing by developing user-friendly apps with features like virtual coaching, automated alerts, and predictive analytics. Several players are also investing in remote patient monitoring platforms to support virtual care models. In response to growing demand for personalized solutions, companies are incorporating machine learning to offer tailored recommendations. These efforts collectively reflect a strategic push toward more connected, data-driven diabetes care, driving innovation and expanding the United States digital diabetes management market.

The report provides a comprehensive analysis of the competitive landscape in the United States digital diabetes management market with detailed profiles of all major companies.

Latest News and Developments:

• June 2025: Welldoc confirmed that its cardiometabolic digital health system will power the recently released Lilly Health™ Personalized Health & Medicine Platform* (Lilly Health app). The Lilly Health app was developed to deliver a personalized user experience for patients interested in or already utilizing Eli Lilly and Company's incretin-based treatments for the management of cardiometabolic disorders, including type 2 diabetes.
• June 2025: IBM and Roche announced the development of Roche’s Accu-Chek^® SmartGuide Predict app, an AI-powered platform for the easier management of diabetes on a daily basis. This collaborative launch demonstrates the necessity of cross-industry teamwork and cooperation in order to help diabetic individuals with the easy delivery of healthcare solutions in their everyday lives.
• February 2025: Byram Healthcare introduced the ByramConnect, a Welldoc App-powered tailored digital health platform. The platform analyzes member information across six health dimensions using the Welldoc App's sophisticated AI features to help improve outcomes for individuals suffering from type 1 or type 2 diabetes and related chronic illnesses, including weight management and hypertension.
• October 2024: Eversense 365, the first FDA-approved continuous glucose monitoring (CGM) device in the United States, was introduced by Ascensia Diabetes Care to assist people with type 1 and type 2 diabetes in better controlling their blood sugar levels. Eversense gives customers the ability to check their blood sugar levels in real time by implanting a tiny sensor under the skin of the upper arm and placing a transmitter on the arm just above the sensor. The Eversense app on the user's smartphone receives real-time glucose level data directly from the transmitter.

United States Digital Diabetes Management Market Report Scope:

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the United States digital diabetes management market from 2019-2033.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the United States digital diabetes management market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the United States digital diabetes management industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.